PHS66 Waste And Cost Minimization Of Alkaline Solution By Standardization Processes Control For Ambulatory Hemodialysis: A Simulation Study  by de Moraes, Junior CS & Colugnati, FAB
A136  VA L U E  I N  H E A LT H  1 7  ( 2 0 1 4 )  A 1 - A 2 9 5  
health care expenditures were abstracted from the reimbursement database of 
the NHI (National Health Insurance), multiplied by the corresponding survival 
probabilities, and summed up for lifetime cost with a 3% annual discount rate. 
We used 22,344 cancer patients with hospice care as a comparison group to con-
duct generalized cost-effectiveness analysis and estimate cost-per-QALY (quality-
adjusted life year). Results: Care of patients under PMV and ESRD showed 2.6 
and 0.94-0.99 GDP (gross domestic product= 18,588 US dollars in 2010) of Taiwan 
per QALY, respectively. All of the nine different cancers were reimbursed less than 
1 GDP per QALY. Lung, esophagus and liver cancer were the highest with 0.37-0.46, 
0.20-0.43, and 0.23-0.24, GDP per QALY, respectively. The cumulative incidence rates 
of cancer show a consistent increase for all cancer except those of the stomach, 
nasopharynx, and cervix. ConClusions: The treatments of major cancers in 
Taiwan have been cost-effective, but prevention is still the fundamental solution 
for a sustainable NHI.
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objeCtives: There are few studies about costs of inputs used in hemodialysis and 
among these expenditures, the compounds that make up the dialysate are one of 
the values considered as representative of this therapy. However, there aren’t costs 
studies that guiding solutions. The objective of this article is discuss whether there 
is wasteful of alkaline solutions in ambulatory hemodialysis and hence the pos-
sibility of reduction in cost from the standardization process of establishment of 
dialysate flow in periods between shifts in hemodialysis outpatients. Methods: 
Starting from a observational analytic cross-sectional research from a real case 
study at a hemodyalysis clinic, a study was conducted with simulated twenty case 
scenarios based on different outpatient profiles that affect the solution flow, havig 
ten cases established by standardizing processes control on the dialysate flow in 
recession and other ten without this standartization. The combination of data was 
performed using as a basis the prices of three suppliers of alkali liquid or pow-
der. Results: It was observed savings among the scenarios with standardized 
processes ranging between 7.7% and 33.3% in the alkaline solution cost (powder 
or liquid), by reducing waste. ConClusions: It is possible to restrain the wasteful 
use of alkaline solutions, both powder and liquid. Consequently, its cost from the 
patterning on reducing the flow of dialysate during the intervals between shifts 
observed in the outpatient hemodialysis. However, these results are conditional 
upon the commitment of health professionals, mainly to supervision exercise and 
control of activities in quality function deployment.
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intRoduCtion: The presence of mental disorders at workplace has been related 
with absenteeism and decreasing in work performance and in productivity. There 
are some effective interventions available that can be implemented to reduce the 
socio economic impact of mental disorders like anxiety and depression at the 
workplace. objeCtives: To identify the evidence-based interventions available 
to prevent and to treat anxiety and depression at the workplace and to explore 
in what extent these interventions have impact on reducing the socio economic 
effects of mental disorders. Methods: A search based on depression, anxiety, 
interventions, prevention, workplace, absenteeism, presenteeism, indirect costs 
was built in Medline database. Studies were included if they described the inter-
vention and method and their effects on absenteism, presenteeism and costs at 
workplace. Results: Five main interventions were identified: workplace screening 
for anxiety and depression disorders and care management: interventions are usu-
ally delivered throughout cognitive behavioral therapy (CBT), offered by external 
psychological service providers; CBT through web-based program: it is offered a 
web-based program to selected employees. Benefits come out of tackling the disor-
der and increasing productivity levels due to the reduction of presenteeism; inter-
ventions promoting well-being in the workplace: it includes flexible time schedules, 
career growth opportunities and mental health risk factors recognition training 
program for managers; financial education: workshop for selected employees to 
advise them on how to better manage their debts, reducing financial burden and 
consequently, reducing mental health problems; antidepressant drugs for anxiety 
and depression: these medicines have a positive impact on the work performance 
and on the decrease of absenteeism rate. ConClusions: The studies selected 
demonstrated a clear benefit of five interventions for depression and anxiety at 
workplace: improvement in employees´ performance, in quality of life, reduction 
of health services costs, decrease in absenteeism rate, in accidents, in sick leave 
benefits and in early retirement.
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objeCtives: The purpose of this article is to analyze the efficiency of the Brazilian 
States in the public system of kidney transplant, in the years 2006 and 2011; and 
evaluate the performance of the efficiency of these States throughout this period 
of time. Thus sought to analyze the behavior of States in this sector, before and 
after the institutional changes adopted by SUS in October of 2009. Methods: The 
methodology used was data envelopment analysis (DEA) based on Slack (Slack 
($7,530) for Mbagathi and Moi respectively, and the discounted life time effects were 
to 7.73 years and 6.52 years respectively. ConClusions: ART treatment was the 
most cost effective treatment method and although patients on treatment follow 
up in Moi lived longer, Mbagathi Hospital was most cost effective intervention.
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objeCtives: The Belgian community pharmacist-led PHARMACOP intervention 
provided educational inhalation training sessions and motivational interviewing 
regarding medication use in patients with Chronic Obstructive Pulmonary Disease 
(COPD). The program significantly improved medication adherence and inhala-
tion techniques compared with usual care. This study aimed to evaluate its cost-
effectiveness. Methods: An economic analysis was performed from the Belgian 
health care payer’s perspective. A Markov model was constructed in which a cohort 
of 1,000 patients with COPD receiving the 3-month PHARMACOP-intervention or 
usual care, was followed. This cohort had a mean age of 70 years, 66% were male, 
43% current smokers and patients had a mean Forced Expiratory Volume in 1 sec-
ond of % predicted of 50. Three types of costs were calculated: intervention costs, 
medication costs and exacerbation costs. Outcome measures included the number 
of hospital-treated exacerbations, cost per prevented hospital-treated exacerbation 
and cost per Quality Adjusted Life-Year (QALY) gained. Follow-up was 1 year in 
the basecase analysis. Univariate-, probabilistic sensitivity- and scenario analyses 
(including long-term follow-up) were performed to assess uncertainty. Results: 
In the basecase analysis, the average overall costs per patient for the PHARMACOP-
intervention and usual care were € 2,221 and € 2,448, respectively within the 1-year 
time horizon. This reflects cost savings of € 227 for the PHARMACOP-intervention. 
The PHARMACOP-intervention resulted in the prevention of 71 hospital-treated 
exacerbations (167 for PHARMACOP versus 238 for usual care), i.e. 0.07 (95%CI: 
0.04-0.10) incremental hospital-treated exacerbations per patient. In addition, a 
small (< 0.001 QALYs) increase in QALYs was observed. Results showed robust cost-
savings in various sensitivity analyses. ConClusions: Optimization of current 
pharmacotherapy (e.g. close monitoring of inhalation technique and medication 
adherence) has been shown to be cost-saving and should be considered before 
adding new therapies.
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objeCtives: The USPSTF currently recommends one-time ultrasound screening 
for all men at age 65 years (B recommendation), while screening for female ever-
smokers is a C recommendation due to a perceived small net benefit. Our goal was 
to assess the cost-effectiveness of a one-time ultrasound screening and follow-up 
surveillance for abdominal aortic aneurysm (AAA) in men and women who do and 
do not smoke. Methods: We constructed a Markov model using the best available 
clinical data following screening at age 65. AAA-specific costs (2012 US dollars) were 
assessed from a health care system perspective, benefits were QALYs gained, and 
both costs and benefits were discounted at 3%. To assess the uncertainty around 
model parameters, we conducted a probabilistic sensitivity analysis. Furthermore, 
we tested individual parameter and structural uncertainty using analysis of covari-
ance and one-way sensitivity analyses. Results: The ICER for screening female 
smokers is $24,000 per QALY gained. Other potentially cost-effective options include 
screening all smokers, $49,000 per QALY gained, and all females and male smokers, 
$110,000 per QALY gained. Screening all individuals is not likely to be cost-effective 
with an ICER over $200,000 per QALY gained. The probabilistic sensitivity analysis 
indicates that at willingness-to-pay thresholds of $50,000 and $100,000 per QALY 
gained, screening all smokers is a cost-effective option. The discount rate was the 
only parameter or assumption found to appreciably change the interpretation of 
the final results with a 0% rate making screening everyone cost-effective and a 10% 
rate screening no one the only cost-effective option. ConClusions: To date, few 
women have been included in RCTs, and a trial adequately powered to evaluate the 
net benefits of screening for AAA in women seems unlikely. Our analysis found that 
the group with the most favorable ICER was actually female smokers, with screening 
all smokers also likely to be a cost-effective option.
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objeCtives: This study determined if treatment of major cancers in Taiwan is 
cost-effective compared with other major illnesses. Methods: 395,330 patients 
with pathologically verified cancer, 125,277 patients with end-stage renal dis-
ease (ESRD), and 50,481 under prolonged mechanical ventilations (PMV) during 
1998-2007 were included and followed until 2007-10. Survival functions for these 
patients were extrapolated to lifetime based on a semi-parametric method. A con-
venience sample of measuring utility value with EQ-5D were conducted for 6,189 
cancer patients and 1,401 with other major diseases, which were multiplied with 
survival functions to estimate quality-adjusted life expectancies. The monthly 
